Skip to content

Investigator

Yu Yamaguchi

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · funded by NIGMS, NIA

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$2.3M

Summed across those awards.

First award
Feb 1, 2022

Latest Apr 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Catalytic mechanisms, regulation, and anti-fibrotic roles of the TMEM2 cell surface hyaluronidase

    $1.7M

    Apr 1, 2026NIGMSSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11298793 (opens the source filing in a new tab)

  2. R01

    Microglial heparan sulfate in the modulation of APOE function and neurodegeneration

    $581k

    Feb 1, 2022NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11237087 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources